Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02703714
Title Pembrolizumab and GM-CSF in Biliary Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Robin Kate Kelley

biliary tract cancer


Pembrolizumab + Sargramostim

Age Groups: adult
Covered Countries USA

No variant requirements are available.